Thrombolytic treatment in acute myocardial infarction

Semin Thromb Hemost. 1987 Apr;13(2):186-200. doi: 10.1055/s-2007-1003492.
No abstract available

Publication types

  • Review

MeSH terms

  • Angioplasty, Balloon
  • Anistreplase
  • Coronary Vessels
  • Drug Administration Routes
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Fibrinolytic Agents / therapeutic use*
  • Humans
  • Injections
  • Injections, Intravenous
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy
  • Plasminogen / therapeutic use
  • Plasminogen Activators / therapeutic use
  • Prospective Studies
  • Research Design
  • Streptokinase / adverse effects
  • Streptokinase / therapeutic use
  • Tissue Plasminogen Activator / therapeutic use
  • Urokinase-Type Plasminogen Activator / pharmacology
  • Urokinase-Type Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Anistreplase
  • Plasminogen
  • Streptokinase
  • Plasminogen Activators
  • Tissue Plasminogen Activator
  • Urokinase-Type Plasminogen Activator